Batch record review was performed; the batch met all criteria, including pressure testing, sterility testing, and final visual inspection upon release.The patient status was reported as stable.A previous capa ((b)(4)) was initiated for graft leakage.The complaint issue will continue to be monitored within artegraft, inc.Quality systems, quality assurance trending.Device was discarded by the physician.
|
Artegraft inc.Received an email communication from an authorized distributor that an artegraft (collagen vascular graft) was identified as leaking and explanted.Upon follow-up communications with the physician, it was stated that the graft was pressure tested and flushed per the artegraft ifu.After tunneling the graft began "leaking" and was not able to be used "was never sewed in" (i.E.Anastomic connection).The physician reported that it appeared that there were multiple small leaks from the side walls of the graft.This primary graft was intended to be implanted in the patient's upper arm.As a result, an alternate ptfe graft was implanted and the patient is reported in stable condition.Some conflicting details were initially provided from the distributor such as the physician did not remember pressure testing prior to implanting but tested it after the graft was removed from the patient.It was stated that the physician stitched the venous end first and "filled it up" and saw "oozing".The artegraft was disposed of via medical waste at the hospital and the product was not available for artegraft review.
|